Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.91
+0.56 (0.25%)
AAPL  271.94
-1.73 (-0.63%)
AMD  214.65
+1.22 (0.57%)
BAC  56.03
+0.76 (1.38%)
GOOG  311.01
+2.40 (0.78%)
META  659.33
+0.56 (0.08%)
MSFT  485.80
-0.12 (-0.02%)
NVDA  183.19
+2.20 (1.22%)
ORCL  196.98
+5.01 (2.61%)
TSLA  495.11
+13.91 (2.89%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.